Cargando…
Dexamethasone restrains neutrophils in severe COVID-19
Autor principal: | Flemming, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641536/ https://www.ncbi.nlm.nih.gov/pubmed/34862486 http://dx.doi.org/10.1038/s41577-021-00669-x |
Ejemplares similares
-
Poor nasal immunity can lead to severe COVID-19
por: Flemming, Alexandra
Publicado: (2021) -
Do rogue antibodies make the difference between mild versus severe COVID-19?
por: Flemming, Alexandra
Publicado: (2021) -
Dexamethasone, but Not Vitamin D or A, Dampens the Inflammatory Neutrophil Response to Protect At-risk COVID-19 Patients
por: Hafkamp, Florianne M.J., et al.
Publicado: (2022) -
Diabetes enhances viral loads in COVID-19
por: Flemming, Alexandra
Publicado: (2022) -
Genetic clues for predisposition to severe disease
por: Flemming, Alexandra
Publicado: (2021)